Formulation and evaluation of multiple tablets as a biphasic gastroretentive floating drug delivery system for fenoverine

Acta Pharmaceutica

Volumn 60, Issue 1, 2010, Pages 89-97

  Bandari, Suresh ^a   Eaga, Chandra ^a   Thadishetty, Ashok ^a   Yamsani, Madhusudan ^a  

^a KAKATIYA UNIVERSITY   (India)

Author keywords

Biphasic release; Gastroretention; Multiple matrix tablet; Release kinetics

Indexed keywords

FENOVERINE; DELAYED RELEASE FORMULATION; DRUG CARRIER; GASTROINTESTINAL AGENT; PHENOTHIAZINE DERIVATIVE; TABLET;

ARTICLE; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG RETENTION; DRUG SCREENING; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; GASTROINTESTINAL ABSORPTION; MATRIX TABLET; TABLET COMPRESSION; TABLET FORMULATION; TABLET PROPERTY; ADMINISTRATION AND DOSAGE; COMPARATIVE STUDY; DELAYED RELEASE FORMULATION; MEDICINAL CHEMISTRY; PHARMACOKINETICS; PROCEDURES; SYNTHESIS; TABLET;

CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; GASTROINTESTINAL AGENTS; PHENOTHIAZINES; TABLETS;

EID: 77949478344     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10007-010-0001-3     Document Type: Article

References (15)

1. S. Hwang, H. Park and K. Park, Gastric retentive drug delivery systems, Crit. Rev. Ther. Drug Carrier Syst. 15 (1998) 243-284.
2. B. N. Singh and K. H. Kim, Floating drug delivery systems: An approach to oral controlled drug delivery via gastric retention, J. Control. Rel. 63 (2000) 235-259; DOI: 10.1016/S0168-3659(99)00204-7.
3. E. A. Klausner, E. Lavy, M. Friedman and A. Hoffman, Expandable gastroretentive dosage forms, J. Control. Rel. 90 (2003) 143-162; DOI: 10.1016/S0168-3659(03)00203-7.
4. A. J. Moes, Gastroretentive dosage forms, Crit. Rev. Ther. Drug Carrier Syst. 10 (1993) 143-195.
5. L. Meka, B. Kesavan, V. N. Kalamata, C. M. Eaga, S. Bandari, V. Vobalaboina and M. R. Yamsani, Design and evaluation of polymeric coated minitablets as multiple unit gastroretentive floating drug delivery systems for furosemide, J. Pharm. Sci. 98 (2009) 2122-2132; DOI: 10.1002/jps.21562.
6. R. Gandhi, C. L. Kaul and R. Panchagnula, Extrusion and spheronization in the development of oral controlled release dosage forms, Pharm. Sci. Tech. Today 2 (1999) 160-170; DOI: 10.1016/S1461- -5347(99)00136-144
7. A. Hoffman, M. Donbrow, S. T. Gross, S. Benita and R. Bahat, Fundamentals of release mechanism interpretation in multiparticulate systems: determination of substrate release from single microcapsules and relation between individual and ensemble release kinetics, Int. J. Pharm. 29 (1986) 195-211; DOI: 10.1016/0378-5173(86)90117-1.
8. G. David, J. C. Friedmann, E. Marmo and R. Pierre, Pharmacodynamic profile of fenoverine, a novel modulator of smooth muscle motility, Acta Ther. 12 (1986) 309-335.
9. A. M. Hamid, M. S. Harris, T. Jaweria and I. Y. Rabia, Once-daily tablet formulation and in vitro release evaluation of cefpodoxime using hydroxypropyl methylcellulose: A technical note, AAPS PharmSciTech. 7 (2006) Article 78.
10. S. Bandari, R. Gannu, K. V. S. Naidu and M. R. Yamsani, High performance liquid chromatographic determination of fenoverine in human serum: Application to pharmacokinetic study, J. Liq. Chrom. Rel. Tech. 31 (2008) 2101-2112; DOI: 10.1080/10826070802225379.
11. United States Pharmacopoeia 24/National Formulary 19, USO Convention, Rockville 2002.
12. P. Costa and J. M. Sousa Lobo, Modelling and comparison of dissolution profiles, Eur. J. Pharm. Sci. 13 (2001) 123-133; DOI: 10.1016/S0928-0987(01) 00095-1.
13. W. I. Higuchi, Analysis of data on the medicament release from ointments, J. Pharm. Sci. 51 (1962) 802-804.
14. J. W. Moore and H. H. Flanner, Mathematical comparison of dissolution profiles, Pharm. Tech. 20 (1996) 64-74.
15. K. A. Khan, The concept of dissolution efficiency, J. Pharm. Pharmacol. 27 (1975) 48-49.